scorecardresearch
Wednesday, July 30, 2025
TopicKiran Mazumdar Shaw

Topic: Kiran Mazumdar Shaw

Biotech in India-US initiative iCET can aid access to & availability of drugs — Kiran Mazumdar-Shaw

iCET, an initiative to develop critical and emerging technologies, has just brought biotech & other digital infra within its ambit. Biocon founder was speaking at Global Technology Summit.

Indian civil servants must shed ‘distanced and aloof’ image—the British Raj is behind us

In ‘Transforming the Steel Frame’, Vinod Rai examines the roles and responsibilities of Indian bureaucracy in modern times.

Kiran Mazumdar-Shaw to retire as Director from Infosys board

Kiran Mazumdar-Shaw was appointed to the Infosys' Board in 2014 & became Lead Independent Director in 2018. D Sundaram wll succeed her as the Lead Independent Director from Thursday.

Anil Ambani, Tendulkar among Indians who parked funds in offshore firms, ‘Pandora Papers’ reveal

The investigation is based on nearly 12 million documents obtained by the International Consortium and Investigative Journalists. The list names several prominent Indians and world leaders.

Biocon partners SII to make vaccine, drug manufacturing accessible to developing nations

Under the deal, Biocon Biologics Ltd (BBL) will offer approximately 15% stake to Serum Institute Life Sciences at a post-money valuation of about Rs 35,000 crore.

Nirmala Sitharaman, Roshni Nadar, Kiran Mazumdar-Shaw in Forbes’ 100 most powerful women list

The Forbes list also features young world leaders such as Finland PM Sanna Marin and New Zealand PM Jacinda Ardern, who are steering the Covid fight.

Entrepreneurship not about making money but having purpose, says Kiran Mazumdar-Shaw

Speaking to students of Delhi's government schools, Shaw talked about her journey as a businesswoman and said that one must always think about giving back to society.

In Covid quarantine, Netflix, Amazon Prime were my constant companions: Kiran Mazumdar Shaw

I was expecting the infection to be mild and short-lived. My Covid-19 experience has matched these expectations and I hope that it allays the fear of the virus.

Biocon chief Kiran Mazumdar-Shaw tests positive for Covid-19

The 67-year-old biotechnology veteran tweeted saying her symptoms are mild as of now, and that she hopes it stays that way.

Russia is not world’s first to develop Covid vaccine, says Kiran Mazumdar-Shaw

Biocon co-founder Kiran Mazumdar-Shaw also questioned the launch of a vaccine prior to completion of Phase 3 trials, saying if it's acceptable to Russia, so be it.

On Camera

Meghnad Desai was a man of many passions. Marxian economics, politics to Bollywood

Meghnad’s interest went much beyond economics and politics. This is reflected in his writing, particularly after his retirement as a full-time LSE professor in 2003.

Govt’s earlier FDI limit of 74% in insurance sector has remained underutilised, Parliament told

In the latest budget, the FDI limit was increased to 100 percent, but most foreign companies are not buying such large stakes in the Indian insurance sector.

India to get last of Spain-built C-295 next month, focus now on 1st India-made aircraft

New Delhi: The last of the C-295 transport aircraft that is replacing the ageing Avro fleet of the Indian Air Force (IAF) will be...

Modi’s Bharat vs Indira’s India: 11-yr report card of politics, diplomacy, economy, nationalism

As Narendra Modi becomes India’s second-longest consecutively serving Prime Minister, we look at how he compares with Indira Gandhi across four key dimensions.